LICENSE AGREEMENT between PHARMACYCLICS LLC and XYNOMIC PHARMACEUTICALS, INC. Dated as of February 23, 2017License Agreement • April 15th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is made and entered into effective as of February 23, 2017 (the “Effective Date”) by and between Pharmacyclics LLC, a Delaware limited liability company wholly owned by AbbVie Inc. (“Pharmacyclics”), and Xynomic Pharmaceuticals, Inc., a Wyoming corporation (“Xynomic”). Pharmacyclics and Xynomic are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Non-Competition AgreementNon-Competition Agreement • April 15th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations
NOW THEREFORE, the two parties hereto make and enter into this Agreement on the basis of voluntary, equal and consensual consultations in accordance with relevant laws and regulations of the People’s Republic of China and the place where the Company is located for joint observance.
